This is a randomized , controlled phase I trial , enrolling @ healthy ( previously vaccinated ) male human volunteers , aged @-@ years to receive one dose of either Sabin IPV ( @:@:@ DU/dose ) , adjuvanted Sabin IPV ( @:@:@ DU/dose ) , or conventional Salk IPV ( @:@:@ DU/dose ) .